Stay updated on AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial
Sign up to get notified when there's something new on the AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial page.

Latest updates to the AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check45 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1%
- Check52 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.1%
- Check59 days agoChange DetectedThe AVP-786 program has been discontinued, with all recruitment halted and participants no longer receiving intervention, marking a significant shift from the previously planned Phase 3 study aimed at treating agitation in Alzheimer's patients.SummaryDifference11%
- Check66 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check73 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference0.2%
Stay in the know with updates to AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AVP-786 Efficacy in Alzheimer's Agitation Clinical Trial page.